HUMANA INC
HUMAPI behind this page
HUM FY 2025 request
Playground key active
/api/financials?ticker=HUM&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Premiums Earned Net | 122,825 | 112,104 | +9.6% |
Show Product Lines breakouts |
|||
| Product | 122,825 | 112,104 | +9.6% |
| Product · Insurance | 122,825 | 112,104 | +9.6% |
| Revenue From Contract With Customer Including Assessed Tax | 5,833 | 4,431 | +31.6% |
Show Product Lines breakouts |
|||
| Service | 5,833 | 4,431 | +31.6% |
| Service · CenterWell | 4,816 | 3,465 | +39.0% |
| Service · Insurance | 1,017 | 966 | +5.3% |
| Investment Income Interest And Dividend | 1,006 | 1,226 | -17.9% |
| Revenue | 129,664 | 117,761 | +10.1% |
Show Product Lines breakouts |
|||
| External Revenues | 128,658 | 116,535 | +10.4% |
| External Revenues · CenterWell | 4,816 | 3,465 | +39.0% |
| External Revenues · Insurance | 123,842 | 113,070 | +9.5% |
Show Business Segments breakouts |
|||
| CenterWell · Eliminations/ Corporate | 17,657 | 16,471 | +7.2% |
| CenterWell · Operating Segments | 22,473 | 19,936 | +12.7% |
| Insurance · Eliminations/ Corporate | 4 | 4 | 0.0% |
| Insurance · Operating Segments | 124,563 | 113,764 | +9.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 3,528 | 3,098 | +13.9% |
Show Consolidation Items breakouts |
|||
| Eliminations/ Corporate | -17,372 | -15,939 | -9.0% |
| Intersegment Elimination | -17,661 | -16,475 | -7.2% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Gentiva Hospice | 2,054 | 1,994 | +3.0% |
| Policyholder Benefits And Claims Incurred Net | 110,812 | 100,664 | +10.1% |
Show Business Segments breakouts |
|||
| Insurance · Operating Segments | 111,043 | 101,299 | +9.6% |
Show Consolidation Items breakouts |
|||
| Eliminations/ Corporate | -231 | -635 | +63.6% |
| Selling, General & Administrative | 15,450 | 13,696 | +12.8% |
Show Business Segments breakouts |
|||
| CenterWell · Operating Segments | 20,915 | 18,383 | +13.8% |
| Insurance · Operating Segments | 11,260 | 10,443 | +7.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 3,274 | 2,588 | +26.5% |
Show Consolidation Items breakouts |
|||
| Eliminations/ Corporate | -16,725 | -15,130 | -10.5% |
| Depreciation And Amortization | 698 | 839 | -16.8% |
Show Business Segments breakouts |
|||
| CenterWell · Operating Segments | 219 | 224 | -2.2% |
| Insurance · Operating Segments | 596 | 733 | -18.7% |
Show Consolidation Items breakouts |
|||
| Eliminations/ Corporate | -117 | -118 | +0.8% |
| Benefits Losses And Expenses | 126,960 | 115,199 | +10.2% |
Show Business Segments breakouts |
|||
| CenterWell · Operating Segments | 21,134 | 18,607 | +13.6% |
| Insurance · Operating Segments | 122,899 | 112,475 | +9.3% |
Show Consolidation Items breakouts |
|||
| Eliminations/ Corporate | -17,073 | -15,883 | -7.5% |
| Operating Income | 2,704 | 2,562 | +5.5% |
Show Business Segments breakouts |
|||
| CenterWell · Operating Segments | 1,339 | 1,329 | +0.8% |
| Insurance · Operating Segments | 1,664 | 1,289 | +29.1% |
Show Consolidation Items breakouts |
|||
| Eliminations/ Corporate | -299 | -56 | -433.9% |
| Gain Loss On Sale Of Business | 67 | — | — |
Show Consolidated Entities breakouts |
|||
| Parent Company | 67 | — | — |
| Interest Expense | 631 | 660 | -4.4% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 623 | 655 | -4.9% |
| Other Non-Operating Income (Expense) | 451 | 181 | +149.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -62 | -115 | +46.1% |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | 1,555 | 1,721 | -9.6% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -977 | -758 | -28.9% |
| Income Tax Expense (Benefit) | 250 | 413 | -39.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -361 | -91 | -296.7% |
| Income Loss From Equity Method Investments | -102 | -94 | -8.5% |
| Net Income | 1,203 | 1,214 | -0.9% |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | 15 | 7 | +114.3% |
| Parent | 1,188 | 1,207 | -1.6% |
| Retained Earnings | 1,188 | 1,207 | -1.6% |
| Net Income Loss Attributable To Noncontrolling Interest | -15 | -7 | -114.3% |
| Net Income | 1,188 | 1,207 | -1.6% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 1,188 | 1,207 | -1.6% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Gentiva Hospice | -84 | -92 | +8.7% |
| EPS (Basic) | 9.87 | 10.01 | -1.4% |
| EPS (Diluted) | 9.84 | 9.98 | -1.4% |
| Total Costs & Expenses (FY) | — | — | — |
Show Consolidated Entities breakouts |
|||
| Parent Company | 4,500 | 3,971 | +13.3% |
| Income Before Taxes | 1,438 | 1,620 | -11.2% |
| Comprehensive Income | 1,622 | 1,139 | +42.4% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 1,622 | 1,139 | +42.4% |
| Other Comprehensive Income | 434 | -68 | +738.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 434 | -68 | +738.2% |
| Wtd Avg Shares (Basic) | 120,454 | 120,571 | -0.1% |
| Wtd Avg Shares (Diluted) | 120,826 | 120,869 | -0.0% |
| Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 | 110,812 | 100,664 | +10.1% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 4,200 | 2,221 | +89.1% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 1,328 | 329 | +303.6% |
| Short-Term Investments | 15,703 | 18,214 | -13.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 215 | 233 | -7.7% |
| Receivables Net Current | 3,270 | 2,704 | +20.9% |
Show Consolidated Entities breakouts |
|||
| Parent Company · Subsidiaries | 3,342 | 2,874 | +16.3% |
| Other Assets Current | 9,560 | 6,676 | +43.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 1,854 | 595 | +211.6% |
| Total Current Assets | 32,733 | 29,815 | +9.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 6,739 | 4,031 | +67.2% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Gentiva Hospice | 430 | 407 | +5.7% |
| Accounts Receivable (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Service | 367 | 360 | +1.9% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 2,231 | 2,532 | -11.9% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 1,653 | 1,876 | -11.9% |
| Available For Sale Securities Debt Securities Noncurrent | 493 | 421 | +17.1% |
| Goodwill | 9,686 | 9,631 | +0.6% |
Show Business Segments breakouts |
|||
| CenterWell | 7,023 | 6,968 | +0.8% |
| Insurance | 2,663 | 2,663 | 0.0% |
Show Reporting Unit breakouts |
|||
| Home Solutions Reporting Unit | 4.4 | — | — |
| Other Non-Current Assets | 3,128 | 3,383 | -7.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 944 | 364 | +159.3% |
| Total Assets | 48,909 | 46,479 | +5.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 40,852 | 37,282 | +9.6% |
| Operating Lease Right-of-Use Assets | 485 | 445 | +9.0% |
| Intangible Assets (Q) | — | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Contractual Rights | 2 | 3 | -33.3% |
| Customer Contracts | 40 | 206 | -80.6% |
| Noncompetes and other | 27 | 34 | -20.6% |
| Trade Names | 7 | 20 | -65.0% |
| Other Assets | |||
| Equity Method Investments | 638 | 697 | -8.5% |
| Current Liabilities | |||
| Liability For Claims And Claims Adjustment Expense | 9,967 | 10,440 | -4.5% |
| Accounts Payable And Accrued Liabilities Current | 5,717 | 5,259 | +8.7% |
| Book Overdraft Liability | 306 | 403 | -24.1% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 43 | 70 | -38.6% |
| Deferred Revenue (Current) | 356 | 260 | +36.9% |
| Total Current Liabilities | 16,346 | 16,939 | -3.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 10,402 | 9,392 | +10.8% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Gentiva Hospice | 327 | 413 | -20.8% |
| Accounts Payable (Q) | — | — | — |
Show Consolidated Entities breakouts |
|||
| Parent Company · Subsidiaries | 7,505 | 7,144 | +5.1% |
| Non-Current Liabilities | |||
| Long-Term Debt | 12,369 | 11,144 | +11.0% |
Show Debt Instrument breakouts |
|||
| $1,000 million, 5.750% due April, 15, 2054 · Senior Notes | 991 | 972 | +2.0% |
| $1,500 million, 5.375% due April, 15, 2031 · Senior Notes | 1,493 | 1,226 | +21.8% |
| $250 million, 8.150% due June 15, 2038 · Senior Notes | 260 | 260 | 0.0% |
| $400 million, 4.625% due December 1, 2042 · Senior Notes | 374 | 366 | +2.2% |
| $400 million, 4.800% due March 15, 2047 · Senior Notes | 396 | 392 | +1.0% |
| $500 million, 3.125% due August 15, 2029 · Senior Notes | 388 | 433 | -10.4% |
| $500 million, 3.950% due August 15, 2049 · Senior Notes | 517 | 505 | +2.4% |
| $500 million, 4.875% due April 1, 2030 · Senior Notes | 497 | 497 | 0.0% |
| $500 million, 5.750% due December 1, 2028 · Senior Notes | 497 | 496 | +0.2% |
| $500 million, 5.750% due March 1, 2028 · Senior Notes | 491 | 490 | +0.2% |
| $500 million, 6.000% due May 1, 2055 · Senior Notes | 486 | — | — |
| $600 million, 3.950% due March 15, 2027 · Senior Notes | 466 | 538 | -13.4% |
| $750 million, 1.350% due February 3, 2027 · Senior Notes | 563 | 689 | -18.3% |
| $750 million, 2.150% due February 3, 2032 · Senior Notes | 592 | 744 | -20.4% |
| $750 million, 3.700% due March 23, 2029 · Senior Notes | 586 | 585 | +0.2% |
| $750 million, 4.950% due October 1, 2044 · Senior Notes | 717 | 714 | +0.4% |
| $750 million, 5.500% due March 15, 2053 · Senior Notes | 727 | 705 | +3.1% |
| $750 million, 5.550% due May 1, 2035 · Senior Notes | 746 | — | — |
| $750 million, 5.875% due March 1, 2033 · Senior Notes | 750 | 726 | +3.3% |
| $850 million, 5.950% due March 15, 2034 · Senior Notes | 832 | 806 | +3.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 12,369 | 11,144 | +11.0% |
| Other Non-Current Liabilities | 2,457 | 1,951 | +25.9% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 424 | 371 | +14.3% |
| Total Liabilities | 31,172 | 30,034 | +3.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 23,195 | 20,907 | +10.9% |
| Operating Lease Liabilities | 418 | 392 | +6.6% |
| Stockholders' Equity | |||
| Common Stock | 33 | 33 | 0.0% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 33 | 33 | 0.0% |
| Additional Paid In Capital Common Stock | 3,600 | 3,463 | +4.0% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 3,600 | 3,463 | +4.0% |
| Retained Earnings | 29,075 | 28,317 | +2.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 29,075 | 28,317 | +2.7% |
| Accumulated Other Comprehensive Income | -633 | -1,067 | +40.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -633 | -1,067 | +40.7% |
| Treasury Stock Common Value | -14,418 | -14,371 | -0.3% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -14,418 | -14,371 | -0.3% |
| Total Stockholders' Equity | 17,657 | 16,375 | +7.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 17,657 | 16,375 | +7.8% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Gentiva Hospice | 1,335 | 1,468 | -9.1% |
| Minority Interest | 80 | 70 | +14.3% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 17,737 | 16,445 | +7.9% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -633 | -1,067 | +40.7% |
| Additional Paid In Capital | 3,600 | 3,463 | +4.0% |
| Common Stock | 33 | 33 | 0.0% |
| Noncontrolling Interest | 80 | 70 | +14.3% |
| Parent | 17,657 | 16,375 | +7.8% |
| Retained Earnings | 29,075 | 28,317 | +2.7% |
| Treasury Stock Common | -14,418 | -14,371 | -0.3% |
| Total Liabilities & Equity | 48,909 | 46,479 | +5.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 40,852 | 37,282 | +9.6% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Stock-Based Compensation | 241 | 207 | +16.4% |
| Deferred Income Taxes | 75 | -192 | +139.1% |
| Change in Deferred Revenue | 96 | -6 | +1700.0% |
| Net Cash from Operations | 921 | 2,966 | -68.9% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 2,495 | 3,454 | -27.8% |
| Investing Activities | |||
| Capital Expenditures | -546 | -575 | +5.0% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -440 | -426 | -3.3% |
| Purchases of Investments | -6,440 | -8,185 | +21.3% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -3 | -16 | +81.2% |
| Net Cash from Investing | 2,273 | -2,952 | +177.0% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -1,400 | -2,247 | +37.7% |
| Financing Activities | |||
| Share Repurchases | -151 | -817 | +81.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -151 | -817 | +81.5% |
| Debt Issuance Costs | -5 | -7 | +28.6% |
| Net Cash from Financing | -1,215 | -2,487 | +51.1% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -96 | -1,128 | +91.5% |
| Supplemental | |||
| Interest Paid | 628 | 584 | +7.5% |
| Other Cash Flow | |||
| Net Change in Cash | 1,979 | -2,473 | +180.0% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 999 | 79 | +1164.6% |
Values in millions USD. Source: SEC EDGAR 10-K filing.